Keisuke Horiuchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Keisuke Horiuchi has a total of 620 co-authors. Here are the top co-authors by number of shared publications:
Yoshiaki Toyama
Department of Orthopaedic Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
36 shared publicationsHideo Morioka
Department of Orthopaedic Surgery, Keio University School of Medicine
26 shared publicationsMorio Matsumoto
Department of Orthopaedic Surgery Keio University School of Medicine Shinjuku Tokyo Japan
26 shared publicationsMasaya Nakamura
Department of Orthopedic Surgery, Keio University School of Medicine, Tokyo, Japan
24 shared publicationsKazuhiro Chiba
Department of Orthopedic Surgery National Defense Medical College Saitama Japan
20 shared publicationsMasaki Yoda
Laboratory of Cell and Tissue Biology, Keio University School of Medicine, Japan
17 shared publications
Latest Publications
- Open Access
- 14 November 2026
- Published by Springer Nature in Scientific Reports
Chronic kidney disease is associated with reduced satellite cell number and impaired muscle regeneration in mice
Chronic kidney disease (CKD) is often associated with muscle wasting and impaired regeneration, but the underlying cellular mechanisms remain incompletely understood. To better understand how CKD compromises muscle regeneration, we investigated the effects of uremic toxins on muscle satellite cells (SCs), which are indispensable for myofiber formation. CKD was induced in mice by feeding them an adenine-containing diet. As expected, the CKD mice exhibited lower muscle mass and weaker grip strength than the control mice. Flow cytometry and immunohistochemistry revealed a significant decrease in the number of SCs in CKD mice. Conversely, the ratio of propidium iodide-positive SCs increased in CKD mice, indicating increased cell death. Muscle regeneration processes appeared normal after injury in CKD mice; however, muscle mass did not fully recover to baseline levels. Exposure of primary SCs to the uremic toxin indoxyl sulfate in vitro led to increased apoptosis and reduced cell viability. Notably, despite the reduced number of SCs, indoxyl sulfate did not obviously impair myotube formation in vitro, suggesting that SCs retain their myogenic capacity under CKD conditions. These findings suggest that uremic toxins primarily impair SC survival rather than differentiation, and that defective muscle regeneration is due, at least in part, to a reduced number of SCs in CKD mice. Our results suggest that maintaining the SC pool is crucial for preserving muscle regeneration capacity in CKD patients.
- 14 November 2026
- Published by Springer Nature in Scientific Reports
Open AccessChronic kidney disease is associated with reduced satellite cell number and impaired muscle regeneration in mice
Chronic kidney disease (CKD) is often associated with muscle wasting and impaired regeneration, but the underlying cellular mechanisms remain incompletely understood. To better understand how CKD compromises muscle regeneration, we investigated the effects of uremic toxins on muscle satellite cells (SCs), which are indispensable for myofiber formation. CKD was induced in mice by feeding them an adenine-containing diet. As expected, the CKD mice exhibited lower muscle mass and weaker grip strength than the control mice. Flow cytometry and immunohistochemistry revealed a significant decrease in the number of SCs in CKD mice. Conversely, the ratio of propidium iodide-positive SCs increased in CKD mice, indicating increased cell death. Muscle regeneration processes appeared normal after injury in CKD mice; however, muscle mass did not fully recover to baseline levels. Exposure of primary SCs to the uremic toxin indoxyl sulfate in vitro led to increased apoptosis and reduced cell viability. Notably, despite the reduced number of SCs, indoxyl sulfate did not obviously impair myotube formation in vitro, suggesting that SCs retain their myogenic capacity under CKD conditions. These findings suggest that uremic toxins primarily impair SC survival rather than differentiation, and that defective muscle regeneration is due, at least in part, to a reduced number of SCs in CKD mice. Our results suggest that maintaining the SC pool is crucial for preserving muscle regeneration capacity in CKD patients.
- Open Access
- 2 September 2026
- Published by Springer Nature in International Orthopaedics
- Vol. 50 (10) , 2729-2741
Historical contributions and future horizons of Japanese orthopaedic oncology: from surgical innovation to nationwide collaborations
Purpose: Bone and soft tissue sarcomas are rare, heterogeneous malignancies presenting major diagnostic and therapeutic challenges. Over the past century, Japanese orthopaedic surgeons have occupied a unique position as both primary surgeons and comprehensive oncologists. On the occasion of the Centennial of the Japanese Orthopaedic Association (JOA), this review synthesizes the key historical milestones and future prospects of Japanese orthopaedic oncology. Methods: A narrative synthesis was structured across five consolidated domains: (1) Surgical Innovation; (2) Advanced Basic Research and Novel Therapeutics; (3) The Japan Bone and Soft Tissue Tumor Registry (JBSTTR); (4) Nationwide Collaborative Research Groups and Multidisciplinary Platforms; and (5) Onco-Orthopaedics and Future Musculoskeletal Care. Results: Japanese orthopaedic oncologists established quantitative surgical margin concepts, pioneered Total En Bloc Spondylectomy (TES) for spinal tumours, and developed recycled treated autografts (freezing, pasteurization, and irradiation). Translational research milestones encompass caffeine-potentiated chemotherapy, peptide-based immunotherapy, oncolytic viral therapies, Japan’s first investigator-initiated clinical trial in oncology, and carbon-ion radiotherapy. Furthermore, a robust nationwide infrastructure has been forged through six decades of the JBSTTR alongside collaborative research engines—the Japanese Musculoskeletal Oncology Group (JMOG), the Japan Clinical Oncology Group Bone and Soft Tissue Tumor Study Group (JCOG-BSTTSG), and the Japan Ewing Sarcoma Study Group (JESS)—and the multidisciplinary platform Japanese Association of Sarcoma Treatment and Research (JSTAR). Expanding beyond primary sarcoma care, the conceptual framework of Onco-Orthopaedics has pioneered a holistic paradigm for managing locomotive syndrome in cancer patients "Cancer Locomo". Conclusion: The surgeon-led collaborative ecosystem in Japan bridges surgical precision, translational science, and nationwide multidisciplinary platforms, offering a sustainable model for advancing musculoskeletal oncology.
- 2 September 2026
- Published by Springer Nature in International Orthopaedics
- Vol. 50 (10) , 2729-2741
Open AccessHistorical contributions and future horizons of Japanese orthopaedic oncology: from surgical innovation to nationwide collaborations
Purpose: Bone and soft tissue sarcomas are rare, heterogeneous malignancies presenting major diagnostic and therapeutic challenges. Over the past century, Japanese orthopaedic surgeons have occupied a unique position as both primary surgeons and comprehensive oncologists. On the occasion of the Centennial of the Japanese Orthopaedic Association (JOA), this review synthesizes the key historical milestones and future prospects of Japanese orthopaedic oncology. Methods: A narrative synthesis was structured across five consolidated domains: (1) Surgical Innovation; (2) Advanced Basic Research and Novel Therapeutics; (3) The Japan Bone and Soft Tissue Tumor Registry (JBSTTR); (4) Nationwide Collaborative Research Groups and Multidisciplinary Platforms; and (5) Onco-Orthopaedics and Future Musculoskeletal Care. Results: Japanese orthopaedic oncologists established quantitative surgical margin concepts, pioneered Total En Bloc Spondylectomy (TES) for spinal tumours, and developed recycled treated autografts (freezing, pasteurization, and irradiation). Translational research milestones encompass caffeine-potentiated chemotherapy, peptide-based immunotherapy, oncolytic viral therapies, Japan’s first investigator-initiated clinical trial in oncology, and carbon-ion radiotherapy. Furthermore, a robust nationwide infrastructure has been forged through six decades of the JBSTTR alongside collaborative research engines—the Japanese Musculoskeletal Oncology Group (JMOG), the Japan Clinical Oncology Group Bone and Soft Tissue Tumor Study Group (JCOG-BSTTSG), and the Japan Ewing Sarcoma Study Group (JESS)—and the multidisciplinary platform Japanese Association of Sarcoma Treatment and Research (JSTAR). Expanding beyond primary sarcoma care, the conceptual framework of Onco-Orthopaedics has pioneered a holistic paradigm for managing locomotive syndrome in cancer patients "Cancer Locomo". Conclusion: The surgeon-led collaborative ecosystem in Japan bridges surgical precision, translational science, and nationwide multidisciplinary platforms, offering a sustainable model for advancing musculoskeletal oncology.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Orthopedics
- Vol. 2026 (1)
Periprosthetic Joint Infection Following Acupuncture Treatment in a Patient With Total Hip Arthroplasty: A Rare but Severe Complication
An 81‐year‐old woman underwent total hip arthroplasty for a femoral neck fracture. Five days after surgery, she fell and sustained a periprosthetic fracture, for which she subsequently underwent revision surgery. Her postoperative course was uneventful; however, 4 years after surgery, she noticed redness and warmth over her left hip several days after receiving acupuncture. Purulent discharge subsequently developed, prompting her to visit our hospital. Imaging studies revealed abscess formation and osteolysis around the left hip, leading to a diagnosis of periprosthetic infection. After conservative treatments failed, surgical debridement and continuous local antibiotic perfusion therapy were performed. Her condition improved, and she was discharged home, ambulatory with a cane. Although serum inflammatory markers remained mildly elevated, suggesting a low‐grade infection, there has been no recurrence of purulent discharge, and she has returned to her usual daily activities. Periprosthetic infection is a highly challenging complication, often resulting in the removal of implants and leading to a significantly diminished quality of life. Although acupuncture is generally regarded as safe, this case illustrates that deep infection can occur in patients with prosthetic joints. While a complete cure was not achieved in this case, the use of CLAP therapy contributed to clinical improvement and functional recovery, highlighting its potential role as an adjunctive treatment strategy. Given the potential risks of infection, physicians should inform patients with artificial joints about the potential infectious risks of acupuncture.
- 1 January 2026
- Published by Wiley in Case Reports in Orthopedics
- Vol. 2026 (1)
Open AccessPeriprosthetic Joint Infection Following Acupuncture Treatment in a Patient With Total Hip Arthroplasty: A Rare but Severe Complication
An 81‐year‐old woman underwent total hip arthroplasty for a femoral neck fracture. Five days after surgery, she fell and sustained a periprosthetic fracture, for which she subsequently underwent revision surgery. Her postoperative course was uneventful; however, 4 years after surgery, she noticed redness and warmth over her left hip several days after receiving acupuncture. Purulent discharge subsequently developed, prompting her to visit our hospital. Imaging studies revealed abscess formation and osteolysis around the left hip, leading to a diagnosis of periprosthetic infection. After conservative treatments failed, surgical debridement and continuous local antibiotic perfusion therapy were performed. Her condition improved, and she was discharged home, ambulatory with a cane. Although serum inflammatory markers remained mildly elevated, suggesting a low‐grade infection, there has been no recurrence of purulent discharge, and she has returned to her usual daily activities. Periprosthetic infection is a highly challenging complication, often resulting in the removal of implants and leading to a significantly diminished quality of life. Although acupuncture is generally regarded as safe, this case illustrates that deep infection can occur in patients with prosthetic joints. While a complete cure was not achieved in this case, the use of CLAP therapy contributed to clinical improvement and functional recovery, highlighting its potential role as an adjunctive treatment strategy. Given the potential risks of infection, physicians should inform patients with artificial joints about the potential infectious risks of acupuncture.
- Open Access
- 7 November 2025
- Published by Wiley in FASEB BioAdvances
- Vol. 7 (11) , e70070
Doxorubicin Impairs Skeletal Muscle Regeneration by Dysregulating the Early Inflammatory Response
For patients with certain types of malignant tumors, chemotherapy is administered before and/or after surgery. However, the potential impact of chemotherapeutic agents on tissue regeneration and wound healing after surgery is not fully understood. In this study, we examined the possible effects of doxorubicin (DOX), one of the most widely used chemotherapeutic agents, on muscle regeneration using a mouse muscle injury model. Histologic analysis revealed that DOX significantly impairs muscle regeneration, resulting in reduced muscle mass and fibrosis when administered during the early phase of the inflammatory response following injury. Contrary to our initial assumption, DOX administration did not suppress the proliferation of satellite cells or the expression of myogenic transcripts. Rather, DOX delayed the infiltration of immune cells to the injury site, which most likely resulted in insufficient clearance of necrotic tissues and prolonged immune cell infiltration. Taken together, our findings reveal an unrecognized effect of DOX on muscle regeneration and underscore the critical role of the early inflammatory response in initiating proper muscle regeneration after injury.
- 7 November 2025
- Published by Wiley in FASEB BioAdvances
- Vol. 7 (11) , e70070
Open AccessDoxorubicin Impairs Skeletal Muscle Regeneration by Dysregulating the Early Inflammatory Response
For patients with certain types of malignant tumors, chemotherapy is administered before and/or after surgery. However, the potential impact of chemotherapeutic agents on tissue regeneration and wound healing after surgery is not fully understood. In this study, we examined the possible effects of doxorubicin (DOX), one of the most widely used chemotherapeutic agents, on muscle regeneration using a mouse muscle injury model. Histologic analysis revealed that DOX significantly impairs muscle regeneration, resulting in reduced muscle mass and fibrosis when administered during the early phase of the inflammatory response following injury. Contrary to our initial assumption, DOX administration did not suppress the proliferation of satellite cells or the expression of myogenic transcripts. Rather, DOX delayed the infiltration of immune cells to the injury site, which most likely resulted in insufficient clearance of necrotic tissues and prolonged immune cell infiltration. Taken together, our findings reveal an unrecognized effect of DOX on muscle regeneration and underscore the critical role of the early inflammatory response in initiating proper muscle regeneration after injury.
- 26 February 2025
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 55 (6) , 615-620
Comparative surgical invasiveness of internal fixation for pathological fractures in metastatic bone disease versus traumatic fractures: a quantitative analysis of operative time and blood loss
Objective: The primary aim of this study was to compare the surgical invasiveness of internal fixation for pathological fractures caused by metastatic bone tumors with that for traumatic fractures. The secondary aim was to identify factors contributing to the complexity of surgeries for metastatic bone disease and provide insights for improving surgical strategies by analyzing operative time and blood loss. Methods: Patients undergoing internal fixation for femoral fractures at 10 institutions between January 2021 and December 2023 were included. Traumatic and metastatic pathological fractures were analyzed, excluding patients aged <18 years and those with benign or atypical fractures. Factors influencing blood loss and operative time were assessed using univariate regression and multivariate modeling (P < 0.05). Results: A total of 275 patients (male = 97, female = 178) with a mean age of 76 years were included. Patients had 230 traumatic and 45 metastatic fractures, with proximal fractures being the most common (n = 225). Intramedullary nailing was the predominant fixation method (n = 231). Blood loss and operative times were significantly affected by the fracture cause, site, and reduction procedures (P < 0.05). Metastatic, distal, or diaphyseal fractures and reduction procedures resulted in higher blood loss and longer operative times. Multivariate analysis confirmed these factors as significant predictors. Conclusions: Surgeries for metastatic fractures are more invasive than those for traumatic fractures because of compromised bone integrity and procedural complexity. Operative time is a key indicator of surgical invasiveness, highlighting the need for tailored surgical approaches to manage metastatic bone disease effectively.
- 26 February 2025
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 55 (6) , 615-620
Comparative surgical invasiveness of internal fixation for pathological fractures in metastatic bone disease versus traumatic fractures: a quantitative analysis of operative time and blood loss
Objective: The primary aim of this study was to compare the surgical invasiveness of internal fixation for pathological fractures caused by metastatic bone tumors with that for traumatic fractures. The secondary aim was to identify factors contributing to the complexity of surgeries for metastatic bone disease and provide insights for improving surgical strategies by analyzing operative time and blood loss. Methods: Patients undergoing internal fixation for femoral fractures at 10 institutions between January 2021 and December 2023 were included. Traumatic and metastatic pathological fractures were analyzed, excluding patients aged <18 years and those with benign or atypical fractures. Factors influencing blood loss and operative time were assessed using univariate regression and multivariate modeling (P < 0.05). Results: A total of 275 patients (male = 97, female = 178) with a mean age of 76 years were included. Patients had 230 traumatic and 45 metastatic fractures, with proximal fractures being the most common (n = 225). Intramedullary nailing was the predominant fixation method (n = 231). Blood loss and operative times were significantly affected by the fracture cause, site, and reduction procedures (P < 0.05). Metastatic, distal, or diaphyseal fractures and reduction procedures resulted in higher blood loss and longer operative times. Multivariate analysis confirmed these factors as significant predictors. Conclusions: Surgeries for metastatic fractures are more invasive than those for traumatic fractures because of compromised bone integrity and procedural complexity. Operative time is a key indicator of surgical invasiveness, highlighting the need for tailored surgical approaches to manage metastatic bone disease effectively.
- 17 February 2025
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 55 (6) , 610-614
Predictive variables for intraoperative blood loss and surgical time in resection of malignant soft tissue tumors without reconstruction
Background: Procedural techniques such as dissection and separation of blood vessels or nerves from the tumor for preserving limbs and functions involves high surgical difficulty. We hypothesized the relation of vessel and/or nerve preservation to surgical time and blood loss, accurately reflecting surgical difficulty. In this study, we elucidated the variables affecting surgical time and intraoperative bleeding in patients with malignant soft tissue tumors who did not undergo any reconstruction after tumor resection. Methods: We included 153 patients with malignant oft tissue tumors in the trunk (n = 72), thigh (n = 68), and upper arm (n = 13) at nine institutions. We analyzed the possible predictive variables affecting surgical time and intraoperative bleeding. Results: Overall, the study included 153 patients (85 men and 68 women) with a mean age of 65 years. The tumors were primary soft tissue sarcoma (STS) (n = 114), local recurrent STS (n = 25), and soft tissue metastasis (n = 14). The median number of participating surgeons was three. The mean and median surgical time were 144.6 and 123 min, respectively. The mean and median intraoperative bleeding were 157.1 and 55 mL, respectively. Tumor size, depth, dissection and separation of blood vessels from the tumor, dissection and separation of nerve from the tumor, and the number of participating surgeons were significantly related to the surgical time and intraoperative bleeding. Conclusions: The procedure of dissection and separation of blood vessels and nerves from the tumor were related to surgical time and intraoperative bleeding in patients with malignant soft tissue tumors, especially large and deep tumors.
- 17 February 2025
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 55 (6) , 610-614
Predictive variables for intraoperative blood loss and surgical time in resection of malignant soft tissue tumors without reconstruction
Background: Procedural techniques such as dissection and separation of blood vessels or nerves from the tumor for preserving limbs and functions involves high surgical difficulty. We hypothesized the relation of vessel and/or nerve preservation to surgical time and blood loss, accurately reflecting surgical difficulty. In this study, we elucidated the variables affecting surgical time and intraoperative bleeding in patients with malignant soft tissue tumors who did not undergo any reconstruction after tumor resection. Methods: We included 153 patients with malignant oft tissue tumors in the trunk (n = 72), thigh (n = 68), and upper arm (n = 13) at nine institutions. We analyzed the possible predictive variables affecting surgical time and intraoperative bleeding. Results: Overall, the study included 153 patients (85 men and 68 women) with a mean age of 65 years. The tumors were primary soft tissue sarcoma (STS) (n = 114), local recurrent STS (n = 25), and soft tissue metastasis (n = 14). The median number of participating surgeons was three. The mean and median surgical time were 144.6 and 123 min, respectively. The mean and median intraoperative bleeding were 157.1 and 55 mL, respectively. Tumor size, depth, dissection and separation of blood vessels from the tumor, dissection and separation of nerve from the tumor, and the number of participating surgeons were significantly related to the surgical time and intraoperative bleeding. Conclusions: The procedure of dissection and separation of blood vessels and nerves from the tumor were related to surgical time and intraoperative bleeding in patients with malignant soft tissue tumors, especially large and deep tumors.
- 31 August 2024
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 43 (1) , 14-22
Dual and opposing role of retinoic acid receptor signaling in mesenchymal stem cells for tendon ossification in mice
Heterotopic ossification is abnormal bone formation in soft tissues that occurs primarily after injury and major surgery. This condition often causes local pain and limits joint motion in the affected limb. Currently, there is no effective treatment or prophylaxis for this condition other than surgical removal of the lesion. Recent studies suggest that retinoic acid receptor (RAR) agonists are effective in suppressing heterotopic ossification in patients with Fibrodysplasia Ossificans Progressiva, a congenital disorder characterized by progressive ossification of soft tissue, by suppressing the aberrant differentiation of mesenchymal stem cells in muscle. In this study, we aimed to elucidate the potential use of RAR agonists in suppressing injury‐induced ectopic tendon ossification using a mouse Achilles tenotomy model. Contrary to our initial hypothesis, administration of RAR agonists throughout the experimental period (5 weeks) accelerated ectopic tendon ossification in our model. Of note, in vitro differentiation experiments using tendon‐derived mesenchymal stem cells revealed that RAR agonists play opposing roles in osteogenic and chondrogenic differentiation, promoting the former and suppressing the latter. Indeed, we found that RAR agonists suppressed tendon ossification when administered before cartilage nodule formation, but promoted it when administered after. These results suggest that RAR agonists have a dual and opposing effect on tendon ectopic ossification, depending on the duration and timing of their administration. Our data may provide a basis for further investigation of the potential use of RAR agonists in the treatment of injury‐induced heterotopic ossification.
- 31 August 2024
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 43 (1) , 14-22
Dual and opposing role of retinoic acid receptor signaling in mesenchymal stem cells for tendon ossification in mice
Heterotopic ossification is abnormal bone formation in soft tissues that occurs primarily after injury and major surgery. This condition often causes local pain and limits joint motion in the affected limb. Currently, there is no effective treatment or prophylaxis for this condition other than surgical removal of the lesion. Recent studies suggest that retinoic acid receptor (RAR) agonists are effective in suppressing heterotopic ossification in patients with Fibrodysplasia Ossificans Progressiva, a congenital disorder characterized by progressive ossification of soft tissue, by suppressing the aberrant differentiation of mesenchymal stem cells in muscle. In this study, we aimed to elucidate the potential use of RAR agonists in suppressing injury‐induced ectopic tendon ossification using a mouse Achilles tenotomy model. Contrary to our initial hypothesis, administration of RAR agonists throughout the experimental period (5 weeks) accelerated ectopic tendon ossification in our model. Of note, in vitro differentiation experiments using tendon‐derived mesenchymal stem cells revealed that RAR agonists play opposing roles in osteogenic and chondrogenic differentiation, promoting the former and suppressing the latter. Indeed, we found that RAR agonists suppressed tendon ossification when administered before cartilage nodule formation, but promoted it when administered after. These results suggest that RAR agonists have a dual and opposing effect on tendon ectopic ossification, depending on the duration and timing of their administration. Our data may provide a basis for further investigation of the potential use of RAR agonists in the treatment of injury‐induced heterotopic ossification.
- Open Access
- 7 August 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (8) , e0308445
The alteration of LBX1 expression is associated with changes in parameters related to energy metabolism in mice
The LBX1 gene is located near a single nucleotide polymorphism that is highly associated with susceptibility to adolescent idiopathic scoliosis and is considered one of the strongest candidate genes involved in the pathogenesis of this condition. We have previously found that loss of LBX1 from skeletal muscle results not only in spinal deformity but also in lean body mass, suggesting a potential role for LBX1 in energy metabolism. The purpose of the present study was to test this hypothesis by analyzing the phenotype of mice lacking LBX1 in skeletal muscle with a focus on energy metabolism. We found that loss of LBX1 rendered mice more resistant to high-fat diet-induced obesity, despite comparable food intake between mutant and control mice. Notably, the mutant mice exhibited improved glucose tolerance, increased maximal aerobic capacity, and higher core body temperature compared to control mice. In addition, we found that overexpression of LBX1 decreased glucose uptake in cultured cells. Taken together, our data show that LBX1 functions as a negative regulator of energy metabolism and that loss of LBX1 from skeletal muscle increases systemic energy expenditure resulting in lean body mass. The present study thus suggests a potential association between LBX1 dysfunction and lean body mass in patients with adolescent idiopathic scoliosis.
- 7 August 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (8) , e0308445
Open AccessThe alteration of LBX1 expression is associated with changes in parameters related to energy metabolism in mice
The LBX1 gene is located near a single nucleotide polymorphism that is highly associated with susceptibility to adolescent idiopathic scoliosis and is considered one of the strongest candidate genes involved in the pathogenesis of this condition. We have previously found that loss of LBX1 from skeletal muscle results not only in spinal deformity but also in lean body mass, suggesting a potential role for LBX1 in energy metabolism. The purpose of the present study was to test this hypothesis by analyzing the phenotype of mice lacking LBX1 in skeletal muscle with a focus on energy metabolism. We found that loss of LBX1 rendered mice more resistant to high-fat diet-induced obesity, despite comparable food intake between mutant and control mice. Notably, the mutant mice exhibited improved glucose tolerance, increased maximal aerobic capacity, and higher core body temperature compared to control mice. In addition, we found that overexpression of LBX1 decreased glucose uptake in cultured cells. Taken together, our data show that LBX1 functions as a negative regulator of energy metabolism and that loss of LBX1 from skeletal muscle increases systemic energy expenditure resulting in lean body mass. The present study thus suggests a potential association between LBX1 dysfunction and lean body mass in patients with adolescent idiopathic scoliosis.
- Open Access
- 6 August 2024
- Published by Wiley in Cancer Science
- Vol. 115 (10) , 3483-3485
Concerning trends and potential issues in osteosarcoma research publication
- 6 August 2024
- Published by Wiley in Cancer Science
- Vol. 115 (10) , 3483-3485
Open AccessConcerning trends and potential issues in osteosarcoma research publication
- 28 May 2024
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 42 (10) , 2140-2148
Suppression of TNF‐α activity by immobilization rescues Mkx expression and attenuates tendon ossification in a mouse Achilles tenotomy model
Traumatic heterotopic ossification is a condition in which extraskeletal bone formation occurs in soft tissues after injury. It most commonly occurs in patients who had major orthopedic surgery and in those with severe extremity injuries. The lesion causes local pain and can impair motor function of the affected limb, but there is currently no established prophylaxis or treatment for this condition. In this study, we show that immobilization at an early stage of the inflammatory response after injury can attenuate ossification formation in a murine Achilles tenotomy model. Gene expression analysis revealed a decrease in the expression of Tnf and an increase in the expression of Mkx, which encodes one of the master regulators of tendon differentiation, Mohawk. Notably, we found that TNF‐α suppressed the expression of Mkx transcripts and accelerated the osteogenic differentiation of tendon‐derived mesenchymal stem cells (MSCs), suggesting that TNF‐α acts as a negative regulator of Mkx transcription. Consistent with these findings, pharmaceutical inhibition of TNF‐α increased the expression of Mkx transcripts and suppressed bone formation in this mouse model. These findings reveal the previously unrecognized involvement of TNF‐α in regulating tendon MSC fate through suppression of Mkx expression and suggest that TNF‐α is a potential target for preventing traumatic heterotopic ossification.
- 28 May 2024
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 42 (10) , 2140-2148
Suppression of TNF‐α activity by immobilization rescues Mkx expression and attenuates tendon ossification in a mouse Achilles tenotomy model
Traumatic heterotopic ossification is a condition in which extraskeletal bone formation occurs in soft tissues after injury. It most commonly occurs in patients who had major orthopedic surgery and in those with severe extremity injuries. The lesion causes local pain and can impair motor function of the affected limb, but there is currently no established prophylaxis or treatment for this condition. In this study, we show that immobilization at an early stage of the inflammatory response after injury can attenuate ossification formation in a murine Achilles tenotomy model. Gene expression analysis revealed a decrease in the expression of Tnf and an increase in the expression of Mkx, which encodes one of the master regulators of tendon differentiation, Mohawk. Notably, we found that TNF‐α suppressed the expression of Mkx transcripts and accelerated the osteogenic differentiation of tendon‐derived mesenchymal stem cells (MSCs), suggesting that TNF‐α acts as a negative regulator of Mkx transcription. Consistent with these findings, pharmaceutical inhibition of TNF‐α increased the expression of Mkx transcripts and suppressed bone formation in this mouse model. These findings reveal the previously unrecognized involvement of TNF‐α in regulating tendon MSC fate through suppression of Mkx expression and suggest that TNF‐α is a potential target for preventing traumatic heterotopic ossification.